IBDEI0FD ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20646,1,4,0)
 ;;=4^428.33
 ;;^UTILITY(U,$J,358.3,20646,1,5,0)
 ;;=5^Heart Failure, Diastolic, Acute on Chronic
 ;;^UTILITY(U,$J,358.3,20646,2)
 ;;=Heart Failure, Diastolic, Acute on Chronic^328499
 ;;^UTILITY(U,$J,358.3,20647,0)
 ;;=428.40^^137^1219^45
 ;;^UTILITY(U,$J,358.3,20647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20647,1,4,0)
 ;;=4^428.40
 ;;^UTILITY(U,$J,358.3,20647,1,5,0)
 ;;=5^Heart Failure, Diastolic& Systolic
 ;;^UTILITY(U,$J,358.3,20647,2)
 ;;=Heart Failure, Systolic and Diastolic^328596
 ;;^UTILITY(U,$J,358.3,20648,0)
 ;;=428.41^^137^1219^47
 ;;^UTILITY(U,$J,358.3,20648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20648,1,4,0)
 ;;=4^428.41
 ;;^UTILITY(U,$J,358.3,20648,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute
 ;;^UTILITY(U,$J,358.3,20648,2)
 ;;=Heart Failure, Systolic & Diastolic, Acute^328500
 ;;^UTILITY(U,$J,358.3,20649,0)
 ;;=428.42^^137^1219^51
 ;;^UTILITY(U,$J,358.3,20649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20649,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,20649,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,20649,2)
 ;;=^328501
 ;;^UTILITY(U,$J,358.3,20650,0)
 ;;=428.43^^137^1219^50
 ;;^UTILITY(U,$J,358.3,20650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20650,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,20650,1,5,0)
 ;;=5^Heart Failure,Systolic&Diastolic
 ;;^UTILITY(U,$J,358.3,20650,2)
 ;;=^328502
 ;;^UTILITY(U,$J,358.3,20651,0)
 ;;=396.3^^137^1219^10
 ;;^UTILITY(U,$J,358.3,20651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20651,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,20651,1,5,0)
 ;;=5^Aortic and Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,20651,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,20652,0)
 ;;=429.9^^137^1219^26
 ;;^UTILITY(U,$J,358.3,20652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20652,1,4,0)
 ;;=4^429.9
 ;;^UTILITY(U,$J,358.3,20652,1,5,0)
 ;;=5^Diastolic Dysfunction
 ;;^UTILITY(U,$J,358.3,20652,2)
 ;;=^54741
 ;;^UTILITY(U,$J,358.3,20653,0)
 ;;=453.79^^137^1219^25
 ;;^UTILITY(U,$J,358.3,20653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20653,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,20653,1,5,0)
 ;;=5^Chr Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,20653,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,20654,0)
 ;;=453.89^^137^1219^1
 ;;^UTILITY(U,$J,358.3,20654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20654,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,20654,1,5,0)
 ;;=5^AC Venous Emblsm Oth Spec Veins
 ;;^UTILITY(U,$J,358.3,20654,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,20655,0)
 ;;=454.0^^137^1219^78
 ;;^UTILITY(U,$J,358.3,20655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20655,1,4,0)
 ;;=4^454.0
 ;;^UTILITY(U,$J,358.3,20655,1,5,0)
 ;;=5^Varicose Veins
 ;;^UTILITY(U,$J,358.3,20655,2)
 ;;=^125410
 ;;^UTILITY(U,$J,358.3,20656,0)
 ;;=454.2^^137^1219^79
 ;;^UTILITY(U,$J,358.3,20656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20656,1,4,0)
 ;;=4^454.2
 ;;^UTILITY(U,$J,358.3,20656,1,5,0)
 ;;=5^Varicose Veins w/Ulcer&Inflam
 ;;^UTILITY(U,$J,358.3,20656,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,20657,0)
 ;;=271.3^^137^1220^10
 ;;^UTILITY(U,$J,358.3,20657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20657,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,20657,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,20657,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,20658,0)
 ;;=611.1^^137^1220^15
 ;;^UTILITY(U,$J,358.3,20658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20658,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,20658,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,20658,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,20659,0)
 ;;=704.1^^137^1220^16
 ;;^UTILITY(U,$J,358.3,20659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20659,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,20659,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,20659,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,20660,0)
 ;;=251.2^^137^1220^27
 ;;^UTILITY(U,$J,358.3,20660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20660,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,20660,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,20660,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,20661,0)
 ;;=257.2^^137^1220^28
 ;;^UTILITY(U,$J,358.3,20661,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20661,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,20661,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,20661,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,20662,0)
 ;;=253.2^^137^1220^31
 ;;^UTILITY(U,$J,358.3,20662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20662,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,20662,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,20662,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,20663,0)
 ;;=733.00^^137^1220^40
 ;;^UTILITY(U,$J,358.3,20663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20663,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,20663,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,20663,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,20664,0)
 ;;=278.00^^137^1220^37
 ;;^UTILITY(U,$J,358.3,20664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20664,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,20664,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,20664,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,20665,0)
 ;;=278.01^^137^1220^36
 ;;^UTILITY(U,$J,358.3,20665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20665,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,20665,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,20665,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,20666,0)
 ;;=250.80^^137^1220^9
 ;;^UTILITY(U,$J,358.3,20666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20666,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,20666,1,5,0)
 ;;=5^DM Type II with LE Ulcer
 ;;^UTILITY(U,$J,358.3,20666,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,20667,0)
 ;;=250.00^^137^1220^4
 ;;^UTILITY(U,$J,358.3,20667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20667,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,20667,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,20667,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,20668,0)
 ;;=250.40^^137^1220^5
 ;;^UTILITY(U,$J,358.3,20668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20668,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,20668,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,20668,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,20669,0)
 ;;=250.50^^137^1220^8
 ;;^UTILITY(U,$J,358.3,20669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20669,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,20669,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,20669,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,20670,0)
 ;;=250.60^^137^1220^6
 ;;^UTILITY(U,$J,358.3,20670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20670,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,20670,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,20670,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,20671,0)
 ;;=250.70^^137^1220^7
 ;;^UTILITY(U,$J,358.3,20671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20671,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,20671,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,20671,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,20672,0)
 ;;=250.01^^137^1220^3
 ;;^UTILITY(U,$J,358.3,20672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20672,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,20672,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,20672,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,20673,0)
 ;;=272.0^^137^1220^20
 ;;^UTILITY(U,$J,358.3,20673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20673,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,20673,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,20673,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,20674,0)
 ;;=272.1^^137^1220^25
 ;;^UTILITY(U,$J,358.3,20674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20674,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,20674,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,20674,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,20675,0)
 ;;=272.2^^137^1220^22
 ;;^UTILITY(U,$J,358.3,20675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20675,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,20675,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,20675,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,20676,0)
 ;;=275.42^^137^1220^19
 ;;^UTILITY(U,$J,358.3,20676,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20676,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,20676,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,20676,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,20677,0)
 ;;=275.41^^137^1220^26
 ;;^UTILITY(U,$J,358.3,20677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20677,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,20677,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,20677,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,20678,0)
 ;;=276.7^^137^1220^21
 ;;^UTILITY(U,$J,358.3,20678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20678,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,20678,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,20678,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,20679,0)
 ;;=275.2^^137^1220^17
 ;;^UTILITY(U,$J,358.3,20679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20679,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,20679,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,20679,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,20680,0)
 ;;=276.0^^137^1220^23
 ;;^UTILITY(U,$J,358.3,20680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20680,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,20680,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,20680,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,20681,0)
 ;;=276.1^^137^1220^29
 ;;^UTILITY(U,$J,358.3,20681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20681,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,20681,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,20681,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,20682,0)
 ;;=275.3^^137^1220^18
 ;;^UTILITY(U,$J,358.3,20682,1,0)
 ;;=^358.31IA^5^2
